ASND — Ascendis Pharma A/S Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapMomentum Trap

Annual balance sheet for Ascendis Pharma A/S, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2021 December 31st	C2022 December 31st	C2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	20-F	20-F	20-F	20-F	20-F
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	682	735	399	560	616
Net Total Accounts Receivable
Net Total Receivables	23.2	25.6	55.8	177	158
Total Inventory
Prepaid Expenses
Total Current Assets	806	923	703	1,061	1,109
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	126	129	111	98.7	146
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Total Assets	1,085	1,090	826	1,179	1,303
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	100	717	737	908	1,069
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	201	826	971	1,285	1,465
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	884	263	-146	-106	-163
Total Liabilities & Shareholders' Equity	1,085	1,090	826	1,179	1,303
Total Common Shares Outstanding